Top 10 Companies in the (S)-(-)-3‑Chlorostyrene Oxide (CAS No. 115648‑90‑3) Market (2026): Market Leaders Powering Global Demand

MARKET INSIGHTS

Global (S)-(-)-3‑Chlorostyrene oxide (CAS No. 115648‑90‑3) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(S)-(-)-3‑Chlorostyrene oxide is a chiral epoxide compound with the molecular formula C₈H₇ClO, widely recognized as a high‑value enantiopure building block in asymmetric synthesis. Characterized by its single stereocenter and reactive oxirane ring, this compound serves as a critical intermediate in the preparation of pharmaceutically active molecules, agrochemicals, and specialty fine chemicals. Its well‑defined (S)-configuration makes it particularly valuable in stereoselective synthesis pathways where absolute configuration control is essential.

The market is gaining steady momentum, primarily driven by the expanding demand for chiral intermediates within the pharmaceutical industry, where regulatory emphasis on single‑enantiomer drug formulations continues to grow. Furthermore, advancements in asymmetric catalysis and biocatalytic resolution techniques are making the production of enantiopure epoxides more efficient and cost‑effective. Key suppliers of this compound include TCI Chemicals, Sigma‑Aldrich (Merck KGaA), and various fine chemical manufacturers operating across North America, Europe, and Asia‑Pacific.

(S)-(-)-3‑Chlorostyrene oxide (CAS No. 115648‑90‑3) Market – View in Detailed Research Report

🔟 1. Thermo Fisher Scientific (Alfa Aesar)

Headquarters: Waltham, Massachusetts, USA
Key Offering: Broad portfolio of chiral building blocks, including halogenated styrene oxide derivatives

Thermo Fisher’s Alfa Aesar division supplies a wide range of fine chemicals with stringent quality controls. Their (S)-(-)-3‑Chlorostyrene oxide is produced under GMP‑aligned conditions, ensuring high optical purity for pharmaceutical synthesis. The company’s robust supply chain and technical support make it a preferred partner for API developers.

Sustainability/Growth Initiatives:

• Investment in continuous flow epoxidation processes to reduce solvent usage.
• Partnerships with academic laboratories to accelerate biocatalytic route development.
• Commitment to ISO 9001 and ISO 14001 certifications for sustainable operations.

9️⃣ 2. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: High‑purity chiral intermediates and specialty chemicals for research and industry

TCI’s reputation for delivering consistent enantiomeric excess and purity levels makes it a key supplier in the chiral chemistry market. Their production facilities incorporate advanced asymmetric epoxidation catalysts, enabling scalable manufacturing of (S)-(-)-3‑Chlorostyrene oxide.

Sustainability/Growth Initiatives:

• Implementation of green chemistry principles in epoxidation reactions.
• Development of reusable chiral catalysts to lower production costs.
• Expansion of digital supply chain visibility for traceability.

8️⃣ 3. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany / Irving, Texas, USA
Key Offering: Comprehensive catalog of fine chemicals with rigorous analytical data

Sigma‑Aldrich supplies (S)-(-)-3‑Chlorostyrene oxide with detailed certificates of analysis, ensuring compliance with pharmaceutical standards. Their integrated quality management system supports rapid turnaround for custom orders.

Sustainability/Growth Initiatives:

• Adoption of solvent‑free reaction protocols where feasible.
• Collaboration with universities on enzyme‑based epoxidation projects.
• Continuous improvement of packaging to reduce environmental footprint.

7️⃣ 4. Hangzhou Keying Chem Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Custom synthesis and scale‑up of chiral epoxides

Hangzhou Keying focuses on delivering tailored solutions for research and industrial clients. Their flexible manufacturing capacity allows rapid scale‑up for pilot and commercial production of (S)-(-)-3‑Chlorostyrene oxide.

Sustainability/Growth Initiatives:

• Investment in renewable energy for production facilities.
• Implementation of waste‑reduction protocols in epoxidation steps.
• Partnerships with local universities to foster talent in chiral chemistry.

6️⃣ 5. Shanghai Longsheng Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity chiral intermediates for pharmaceutical and fine‑chemical applications

Shanghai Longsheng delivers (S)-(-)-3‑Chlorostyrene oxide with consistent enantiomeric excess, supporting both research‑grade and pharma‑grade demand. Their state‑of‑the‑art purification systems ensure minimal impurities.

Sustainability/Growth Initiatives:

• Adoption of closed‑loop water systems to minimize effluent.
• Use of recyclable reactor vessels for epoxidation.
• Engagement with regulatory bodies to streamline approval pathways.

5️⃣ 6. Combi‑Blocks Inc.

Headquarters: Washington, D.C., USA
Key Offering: Specialty chiral intermediates with customizable purity levels

Combi‑Blocks specializes in delivering high‑purity chiral compounds for academic and industrial research. Their (S)-(-)-3‑Chlorostyrene oxide is available in a range of enantiomeric excesses, allowing researchers to select the optimal grade for their synthesis.

Sustainability/Growth Initiatives:

• Development of micro‑reactor epoxidation processes to cut solvent usage.
• Collaboration with biotech firms to integrate biocatalytic steps.
• Commitment to carbon‑neutral logistics for global shipments.

4️⃣ 7. Acros Organics (Thermo Fisher)

Headquarters: Belgium / United States
Key Offering: Premium chiral building blocks for pharmaceutical research

Acros Organics supplies (S)-(-)-3‑Chlorostyrene oxide with stringent quality checks, ensuring high optical purity for API development. Their focus on analytical rigor supports rigorous validation processes.

Sustainability/Growth Initiatives:

• Implementation of green chemistry guidelines in synthesis protocols.
• Investment in renewable energy sources for manufacturing sites.
• Enhanced packaging solutions to reduce single‑use plastic.

3️⃣ 8. BASF

Headquarters: Ludwigshafen, Germany
Key Offering: Advanced specialty chemicals with a focus on sustainability

BASF’s portfolio includes chiral intermediates for agrochemical and fine‑chemical sectors. Their commitment to high purity and process efficiency makes them a reliable supplier for (S)-(-)-3‑Chlorostyrene oxide.

Sustainability/Growth Initiatives:

• Research into enzyme‑based epoxidation to reduce chemical waste.
• Adoption of circular economy principles in production.
• Partnerships with academic institutions for catalyst development.

2️⃣ 9. Bayer

Headquarters: Leverkusen, Germany
Key Offering: High‑quality chiral intermediates for pharmaceutical and agrochemical applications

Bayer’s expertise in process chemistry supports scalable production of (S)-(-)-3‑Chlorostyrene oxide with consistent optical purity, catering to both research and commercial demands.

Sustainability/Growth Initiatives:

• Implementation of solvent‑free reaction conditions where possible.
• Investment in renewable energy for manufacturing plants.
• Enhanced traceability systems for supply chain transparency.

1️⃣ 10. Wacker Chemie AG

Headquarters: Munich, Germany
Key Offering: Specialty chemicals with a focus on high‑purity chiral intermediates

Wacker Chemie offers (S)-(-)-3‑Chlorostyrene oxide with robust analytical data, supporting pharmaceutical synthesis and advanced research projects.

Sustainability/Growth Initiatives:

• Development of energy‑efficient epoxidation processes.
• Adoption of circular material sourcing for feedstocks.
• Commitment to reducing CO₂ emissions across the supply chain.

---

Download FREE Sample Report: (S)-(-)-3‑Chlorostyrene oxide (CAS No. 115648‑90‑3) Market – View in Detailed Research Report

Get Full Report: (S)-(-)-3‑Chlorostyrene oxide (CAS No. 115648‑90‑3) Market – View in Detailed Research Report

Market Outlook

• Continued emphasis on single‑enantiomer drugs will sustain demand for high‑purity chiral intermediates.
• Biocatalytic routes and flow‑chemistry platforms are expected to lower production costs and improve scalability.
• Geopolitical dynamics in key manufacturing regions will shape supply‑chain resilience.
• Regulatory harmonization across major markets will streamline qualification processes for new suppliers.

Future Trends

• Expansion of enzyme‑based epoxidation with engineered styrene monooxygenases to increase stereoselectivity.
• Integration of continuous flow reactors to enhance throughput and reduce waste.
• Growth of orphan‑drug pipelines demanding chiral building blocks for rare‑disease therapeutics.
• Increased focus on sustainability metrics, driving adoption of green chemistry principles in epoxide synthesis.